Skip to main content
. 2021 Dec 24;14(1):35. doi: 10.3390/v14010035

Figure 3.

Figure 3

Comparison of antiviral activity of sulfated (A) alginic acids against HSV-1 [74,76], (B) ulvans against HSV-1 [45], (C) fucoidans against HSV-1 [77], (D) fucoidans against HSV-1 [73], (E) xylans against HSV-1 [97], (F) linear and branched β-1,4-xylans having same degrees of sulfation against HSV-1 [46,97], (G) xylomannans against HSV-1 [98] and (H) glucans against HCMV and HSV-1 [275] having different degrees of sulfation. Antiviral activity was performed by plaque reduction assay in RC-37 cells (African green monkey kidney cells) (A,C), in HEp-2 cells (human larynx epithelial cells carcinoma, ATCC CCL-23) (B), in Vero cells (D–G) and by GFP-based replication assay in primary human fibroblasts (H).